Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization growth accelerates
Q2 FY2026 depreciation & amortization of $3.93M rose 182.3% year over year, ahead of the +175.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 5.9% from the prior quarter. Over 3 fiscal years it compounded at +103.8% a year.
Context
- Depreciation & amortization amounted to 0.8% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +182.3% holds above the trailing-twelve-month pace of +175.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 6.83M USD
- Year-over-year change
- +116.5%
- 3-year CAGR
- +103.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.83M | +116.5% |
| FY2024 | 2024-12-31 | 3.15M | +77.1% |
| FY2023 | 2023-12-31 | 1.78M | +120.7% |
| FY2022 | 2022-12-31 | 807K | — |
Depreciation & Amortization vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's LTM Jun 2026 depreciation & amortization of $11.95M is the lowest of the 7 companies compared; the peer median is $1.13B.
- Its year-over-year change of +175.4% is the highest of 7, against a peer median of +9.0%.
- Depreciation & amortization amounts to 1.0% of revenue for ALAB, versus a peer median of 8.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.26B | +20.6% | +26.9% | 10.9% | |
| LTM Aug 2026 | $1.97B | -2.6% | -4.5% | 14.2% | |
| LTM Aug 2026 | $1.26B | -4.8% | -2.5% | 13.3% | |
| LTM Jun 2026 | $1B | +21.3% | +2.2% | 5.2% | |
| LTM Aug 2026 | $49.78M | +114.9% | +53.8% | 3.1% | |
| LTM Sep 2026 | $37.77M | -3.8% | -15.1% | 5.7% | |
| LTM Jun 2026 | $11.95M | +175.4% | +103.8% | 1.0% | |
| Peer median (excluding ALAB) | $1.13B | +9.0% | -0.1% | 8.3% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 79.87M | 115.79M | 396.29M | 852.53M |
| Cost of Revenue | 21.19M | 35.97M | 93.59M | 207.26M |
| Gross Profit | 58.68M | 79.83M | 302.7M | 645.26M |
| Gross Margin | 73.5% | 68.9% | 76.4% | 75.7% |
| Research & Development | 73.71M | 73.41M | 200.83M | 304M |
| Selling, General & Admin | 45.16M | 35.92M | 217.94M | 167.84M |
| Operating Expenses | 118.88M | 109.32M | 418.77M | 471.84M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M |
| EBITDA | (56.77M) | (21.17M) | (78.62M) | 224.98M |
| EBITDA Margin | -71.1% | -18.3% | -19.8% | 26.4% |
| Operating Income | (60.19M) | (29.5M) | (116.07M) | 173.42M |
| Operating Margin | -75.4% | -25.5% | -29.3% | 20.3% |
| Interest Income | 2.61M | 6.55M | 34.29M | 44.73M |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 2.61M | 6.55M | 34.29M | 44.73M |
| Income Before Tax | (57.58M) | (22.95M) | (81.78M) | 218.15M |
| Pre-Tax Margin | -72.1% | -19.8% | -20.6% | 25.6% |
| Income Tax Expense | 764K | 3.31M | 1.64M | (981K) |
| Net Income | (58.35M) | (26.26M) | (83.42M) | 219.13M |
| Net Margin | -73.0% | -22.7% | -21.1% | 25.7% |
| EPS (Basic) | (0.45) | (0.17) | (0.64) | 1.32 |
| EPS (Diluted) | (0.45) | (0.17) | (0.64) | 1.22 |
| Weighted Avg Shares | 130.45M | 152.5M | 131.26M | 166.41M |
| Weighted Avg Shares (Diluted) | 130.45M | 152.5M | 131.26M | 179.55M |
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.